ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cognition-Enhancing Drugs Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-30C10234
Home | Market Reports | Health| Pharmacy
Global and United States Cognition Enhancing Drugs Market Report Forecast 2022 2028
BUY CHAPTERS

Global Cognition-Enhancing Drugs Market Insights, Forecast to 2030

Code: QYRE-Auto-30C10234
Report
December 2024
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Accelerated Intelligence
Cognition Therapeutics
Cogstate Ltd
HVMN
Biogen Idec

Cognition-Enhancing Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Cognition-Enhancing Drugs Market

Cognition-Enhancing Drugs Market

Cognition-enhancing drugs are purported to improve mental functions such as cognition, memory, intelligence, motivation, attention and concentration.
The global Cognition-Enhancing Drugs market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Cognition-Enhancing Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Cognition-Enhancing Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Cognition-Enhancing Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cognition-Enhancing Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Cognition-Enhancing Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Cognition-Enhancing Drugs sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Cognition-Enhancing Drugs Market Report

Report Metric Details
Report Name Cognition-Enhancing Drugs Market
CAGR 5%
Segment by Type
  • Oral
  • Injection
Segment by Application
  • Hospital Pharmacies
  • Drug Stores
  • Retail Pharmacies
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Cogstate, HVMN, Biogen Idec
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Cognition-Enhancing Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Cognition-Enhancing Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cognition-Enhancing Drugs sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cognition-Enhancing Drugs Market report?

Ans: The main players in the Cognition-Enhancing Drugs Market are Cogstate, HVMN, Biogen Idec

What are the Application segmentation covered in the Cognition-Enhancing Drugs Market report?

Ans: The Applications covered in the Cognition-Enhancing Drugs Market report are Hospital Pharmacies, Drug Stores, Retail Pharmacies

What are the Type segmentation covered in the Cognition-Enhancing Drugs Market report?

Ans: The Types covered in the Cognition-Enhancing Drugs Market report are Oral, Injection

1 Study Coverage
1.1 Cognition-Enhancing Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Cognition-Enhancing Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Cognition-Enhancing Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 Retail Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Cognition-Enhancing Drugs Sales Estimates and Forecasts 2019-2030
2.2 Global Cognition-Enhancing Drugs Revenue by Region
2.2.1 Global Cognition-Enhancing Drugs Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Cognition-Enhancing Drugs Revenue by Region (2019-2024)
2.2.3 Global Cognition-Enhancing Drugs Revenue by Region (2025-2030)
2.2.4 Global Cognition-Enhancing Drugs Revenue Market Share by Region (2019-2030)
2.3 Global Cognition-Enhancing Drugs Sales Estimates and Forecasts 2019-2030
2.4 Global Cognition-Enhancing Drugs Sales by Region
2.4.1 Global Cognition-Enhancing Drugs Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Cognition-Enhancing Drugs Sales by Region (2019-2024)
2.4.3 Global Cognition-Enhancing Drugs Sales by Region (2025-2030)
2.4.4 Global Cognition-Enhancing Drugs Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Cognition-Enhancing Drugs Sales by Manufacturers
3.1.1 Global Cognition-Enhancing Drugs Sales by Manufacturers (2019-2024)
3.1.2 Global Cognition-Enhancing Drugs Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Cognition-Enhancing Drugs in 2023
3.2 Global Cognition-Enhancing Drugs Revenue by Manufacturers
3.2.1 Global Cognition-Enhancing Drugs Revenue by Manufacturers (2019-2024)
3.2.2 Global Cognition-Enhancing Drugs Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Cognition-Enhancing Drugs Revenue in 2023
3.3 Global Key Players of Cognition-Enhancing Drugs, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Cognition-Enhancing Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Cognition-Enhancing Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Cognition-Enhancing Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Cognition-Enhancing Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Cognition-Enhancing Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Cognition-Enhancing Drugs Sales by Type
4.1.1 Global Cognition-Enhancing Drugs Historical Sales by Type (2019-2024)
4.1.2 Global Cognition-Enhancing Drugs Forecasted Sales by Type (2025-2030)
4.1.3 Global Cognition-Enhancing Drugs Sales Market Share by Type (2019-2030)
4.2 Global Cognition-Enhancing Drugs Revenue by Type
4.2.1 Global Cognition-Enhancing Drugs Historical Revenue by Type (2019-2024)
4.2.2 Global Cognition-Enhancing Drugs Forecasted Revenue by Type (2025-2030)
4.2.3 Global Cognition-Enhancing Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Cognition-Enhancing Drugs Price by Type
4.3.1 Global Cognition-Enhancing Drugs Price by Type (2019-2024)
4.3.2 Global Cognition-Enhancing Drugs Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Cognition-Enhancing Drugs Sales by Application
5.1.1 Global Cognition-Enhancing Drugs Historical Sales by Application (2019-2024)
5.1.2 Global Cognition-Enhancing Drugs Forecasted Sales by Application (2025-2030)
5.1.3 Global Cognition-Enhancing Drugs Sales Market Share by Application (2019-2030)
5.2 Global Cognition-Enhancing Drugs Revenue by Application
5.2.1 Global Cognition-Enhancing Drugs Historical Revenue by Application (2019-2024)
5.2.2 Global Cognition-Enhancing Drugs Forecasted Revenue by Application (2025-2030)
5.2.3 Global Cognition-Enhancing Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Cognition-Enhancing Drugs Price by Application
5.3.1 Global Cognition-Enhancing Drugs Price by Application (2019-2024)
5.3.2 Global Cognition-Enhancing Drugs Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Cognition-Enhancing Drugs Market Size by Type
6.1.1 US & Canada Cognition-Enhancing Drugs Sales by Type (2019-2030)
6.1.2 US & Canada Cognition-Enhancing Drugs Revenue by Type (2019-2030)
6.2 US & Canada Cognition-Enhancing Drugs Market Size by Application
6.2.1 US & Canada Cognition-Enhancing Drugs Sales by Application (2019-2030)
6.2.2 US & Canada Cognition-Enhancing Drugs Revenue by Application (2019-2030)
6.3 US & Canada Cognition-Enhancing Drugs Market Size by Country
6.3.1 US & Canada Cognition-Enhancing Drugs Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Cognition-Enhancing Drugs Sales by Country (2019-2030)
6.3.3 US & Canada Cognition-Enhancing Drugs Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Cognition-Enhancing Drugs Market Size by Type
7.1.1 Europe Cognition-Enhancing Drugs Sales by Type (2019-2030)
7.1.2 Europe Cognition-Enhancing Drugs Revenue by Type (2019-2030)
7.2 Europe Cognition-Enhancing Drugs Market Size by Application
7.2.1 Europe Cognition-Enhancing Drugs Sales by Application (2019-2030)
7.2.2 Europe Cognition-Enhancing Drugs Revenue by Application (2019-2030)
7.3 Europe Cognition-Enhancing Drugs Market Size by Country
7.3.1 Europe Cognition-Enhancing Drugs Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Cognition-Enhancing Drugs Sales by Country (2019-2030)
7.3.3 Europe Cognition-Enhancing Drugs Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Cognition-Enhancing Drugs Market Size
8.1.1 China Cognition-Enhancing Drugs Sales (2019-2030)
8.1.2 China Cognition-Enhancing Drugs Revenue (2019-2030)
8.2 China Cognition-Enhancing Drugs Market Size by Application
8.2.1 China Cognition-Enhancing Drugs Sales by Application (2019-2030)
8.2.2 China Cognition-Enhancing Drugs Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Cognition-Enhancing Drugs Market Size by Type
9.1.1 Asia Cognition-Enhancing Drugs Sales by Type (2019-2030)
9.1.2 Asia Cognition-Enhancing Drugs Revenue by Type (2019-2030)
9.2 Asia Cognition-Enhancing Drugs Market Size by Application
9.2.1 Asia Cognition-Enhancing Drugs Sales by Application (2019-2030)
9.2.2 Asia Cognition-Enhancing Drugs Revenue by Application (2019-2030)
9.3 Asia Cognition-Enhancing Drugs Sales by Region
9.3.1 Asia Cognition-Enhancing Drugs Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Cognition-Enhancing Drugs Revenue by Region (2019-2030)
9.3.3 Asia Cognition-Enhancing Drugs Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Cognition-Enhancing Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Cognition-Enhancing Drugs Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Cognition-Enhancing Drugs Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Cognition-Enhancing Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America Cognition-Enhancing Drugs Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Cognition-Enhancing Drugs Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Cognition-Enhancing Drugs Sales by Country
10.3.1 Middle East, Africa and Latin America Cognition-Enhancing Drugs Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Cognition-Enhancing Drugs Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Cognition-Enhancing Drugs Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Accelerated Intelligence
11.1.1 Accelerated Intelligence Company Information
11.1.2 Accelerated Intelligence Overview
11.1.3 Accelerated Intelligence Cognition-Enhancing Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Accelerated Intelligence Cognition-Enhancing Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Accelerated Intelligence Recent Developments
11.2 Cognition Therapeutics
11.2.1 Cognition Therapeutics Company Information
11.2.2 Cognition Therapeutics Overview
11.2.3 Cognition Therapeutics Cognition-Enhancing Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Cognition Therapeutics Cognition-Enhancing Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Cognition Therapeutics Recent Developments
11.3 Cogstate
11.3.1 Cogstate Company Information
11.3.2 Cogstate Overview
11.3.3 Cogstate Cognition-Enhancing Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Cogstate Cognition-Enhancing Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Cogstate Recent Developments
11.4 HVMN
11.4.1 HVMN Company Information
11.4.2 HVMN Overview
11.4.3 HVMN Cognition-Enhancing Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 HVMN Cognition-Enhancing Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 HVMN Recent Developments
11.5 Biogen Idec
11.5.1 Biogen Idec Company Information
11.5.2 Biogen Idec Overview
11.5.3 Biogen Idec Cognition-Enhancing Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Biogen Idec Cognition-Enhancing Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Biogen Idec Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Cognition-Enhancing Drugs Industry Chain Analysis
12.2 Cognition-Enhancing Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Cognition-Enhancing Drugs Production Mode & Process
12.4 Cognition-Enhancing Drugs Sales and Marketing
12.4.1 Cognition-Enhancing Drugs Sales Channels
12.4.2 Cognition-Enhancing Drugs Distributors
12.5 Cognition-Enhancing Drugs Customers
13 Market Dynamics
13.1 Cognition-Enhancing Drugs Industry Trends
13.2 Cognition-Enhancing Drugs Market Drivers
13.3 Cognition-Enhancing Drugs Market Challenges
13.4 Cognition-Enhancing Drugs Market Restraints
14 Key Findings in The Global Cognition-Enhancing Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
Accelerated Intelligence
Cognition Therapeutics
Cogstate Ltd
HVMN
Biogen Idec
List of Tables
    Table 1. Global Cognition-Enhancing Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Oral
    Table 3. Major Manufacturers of Injection
    Table 4. Global Cognition-Enhancing Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 5. Global Cognition-Enhancing Drugs Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Cognition-Enhancing Drugs Revenue by Region (2019-2024) & (US$ Million)
    Table 7. Global Cognition-Enhancing Drugs Revenue by Region (2025-2030) & (US$ Million)
    Table 8. Global Cognition-Enhancing Drugs Revenue Market Share by Region (2019-2024)
    Table 9. Global Cognition-Enhancing Drugs Revenue Market Share by Region (2025-2030)
    Table 10. Global Cognition-Enhancing Drugs Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global Cognition-Enhancing Drugs Sales by Region (2019-2024) & (K MT)
    Table 12. Global Cognition-Enhancing Drugs Sales by Region (2025-2030) & (K MT)
    Table 13. Global Cognition-Enhancing Drugs Sales Market Share by Region (2019-2024)
    Table 14. Global Cognition-Enhancing Drugs Sales Market Share by Region (2025-2030)
    Table 15. Global Cognition-Enhancing Drugs Sales by Manufacturers (2019-2024) & (K MT)
    Table 16. Global Cognition-Enhancing Drugs Sales Share by Manufacturers (2019-2024)
    Table 17. Global Cognition-Enhancing Drugs Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 18. Global Cognition-Enhancing Drugs Revenue Share by Manufacturers (2019-2024)
    Table 19. Global Key Players of Cognition-Enhancing Drugs, Industry Ranking, 2022 VS 2023 VS 2024
    Table 20. Cognition-Enhancing Drugs Price by Manufacturers 2019-2024 (USD/MT)
    Table 21. Global Cognition-Enhancing Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Cognition-Enhancing Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cognition-Enhancing Drugs as of 2023)
    Table 23. Global Key Manufacturers of Cognition-Enhancing Drugs, Manufacturing Base Distribution and Headquarters
    Table 24. Global Key Manufacturers of Cognition-Enhancing Drugs, Product Offered and Application
    Table 25. Global Key Manufacturers of Cognition-Enhancing Drugs, Date of Enter into This Industry
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Cognition-Enhancing Drugs Sales by Type (2019-2024) & (K MT)
    Table 28. Global Cognition-Enhancing Drugs Sales by Type (2025-2030) & (K MT)
    Table 29. Global Cognition-Enhancing Drugs Sales Share by Type (2019-2024)
    Table 30. Global Cognition-Enhancing Drugs Sales Share by Type (2025-2030)
    Table 31. Global Cognition-Enhancing Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 32. Global Cognition-Enhancing Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 33. Global Cognition-Enhancing Drugs Revenue Share by Type (2019-2024)
    Table 34. Global Cognition-Enhancing Drugs Revenue Share by Type (2025-2030)
    Table 35. Cognition-Enhancing Drugs Price by Type (2019-2024) & (USD/MT)
    Table 36. Global Cognition-Enhancing Drugs Price Forecast by Type (2025-2030) & (USD/MT)
    Table 37. Global Cognition-Enhancing Drugs Sales by Application (2019-2024) & (K MT)
    Table 38. Global Cognition-Enhancing Drugs Sales by Application (2025-2030) & (K MT)
    Table 39. Global Cognition-Enhancing Drugs Sales Share by Application (2019-2024)
    Table 40. Global Cognition-Enhancing Drugs Sales Share by Application (2025-2030)
    Table 41. Global Cognition-Enhancing Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 42. Global Cognition-Enhancing Drugs Revenue by Application (2025-2030) & (US$ Million)
    Table 43. Global Cognition-Enhancing Drugs Revenue Share by Application (2019-2024)
    Table 44. Global Cognition-Enhancing Drugs Revenue Share by Application (2025-2030)
    Table 45. Cognition-Enhancing Drugs Price by Application (2019-2024) & (USD/MT)
    Table 46. Global Cognition-Enhancing Drugs Price Forecast by Application (2025-2030) & (USD/MT)
    Table 47. US & Canada Cognition-Enhancing Drugs Sales by Type (2019-2024) & (K MT)
    Table 48. US & Canada Cognition-Enhancing Drugs Sales by Type (2025-2030) & (K MT)
    Table 49. US & Canada Cognition-Enhancing Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 50. US & Canada Cognition-Enhancing Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 51. US & Canada Cognition-Enhancing Drugs Sales by Application (2019-2024) & (K MT)
    Table 52. US & Canada Cognition-Enhancing Drugs Sales by Application (2025-2030) & (K MT)
    Table 53. US & Canada Cognition-Enhancing Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 54. US & Canada Cognition-Enhancing Drugs Revenue by Application (2025-2030) & (US$ Million)
    Table 55. US & Canada Cognition-Enhancing Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 56. US & Canada Cognition-Enhancing Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 57. US & Canada Cognition-Enhancing Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 58. US & Canada Cognition-Enhancing Drugs Sales by Country (2019-2024) & (K MT)
    Table 59. US & Canada Cognition-Enhancing Drugs Sales by Country (2025-2030) & (K MT)
    Table 60. Europe Cognition-Enhancing Drugs Sales by Type (2019-2024) & (K MT)
    Table 61. Europe Cognition-Enhancing Drugs Sales by Type (2025-2030) & (K MT)
    Table 62. Europe Cognition-Enhancing Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 63. Europe Cognition-Enhancing Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 64. Europe Cognition-Enhancing Drugs Sales by Application (2019-2024) & (K MT)
    Table 65. Europe Cognition-Enhancing Drugs Sales by Application (2025-2030) & (K MT)
    Table 66. Europe Cognition-Enhancing Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 67. Europe Cognition-Enhancing Drugs Revenue by Application (2025-2030) & (US$ Million)
    Table 68. Europe Cognition-Enhancing Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 69. Europe Cognition-Enhancing Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 70. Europe Cognition-Enhancing Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 71. Europe Cognition-Enhancing Drugs Sales by Country (2019-2024) & (K MT)
    Table 72. Europe Cognition-Enhancing Drugs Sales by Country (2025-2030) & (K MT)
    Table 73. China Cognition-Enhancing Drugs Sales by Type (2019-2024) & (K MT)
    Table 74. China Cognition-Enhancing Drugs Sales by Type (2025-2030) & (K MT)
    Table 75. China Cognition-Enhancing Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 76. China Cognition-Enhancing Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 77. China Cognition-Enhancing Drugs Sales by Application (2019-2024) & (K MT)
    Table 78. China Cognition-Enhancing Drugs Sales by Application (2025-2030) & (K MT)
    Table 79. China Cognition-Enhancing Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 80. China Cognition-Enhancing Drugs Revenue by Application (2025-2030) & (US$ Million)
    Table 81. Asia Cognition-Enhancing Drugs Sales by Type (2019-2024) & (K MT)
    Table 82. Asia Cognition-Enhancing Drugs Sales by Type (2025-2030) & (K MT)
    Table 83. Asia Cognition-Enhancing Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 84. Asia Cognition-Enhancing Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 85. Asia Cognition-Enhancing Drugs Sales by Application (2019-2024) & (K MT)
    Table 86. Asia Cognition-Enhancing Drugs Sales by Application (2025-2030) & (K MT)
    Table 87. Asia Cognition-Enhancing Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 88. Asia Cognition-Enhancing Drugs Revenue by Application (2025-2030) & (US$ Million)
    Table 89. Asia Cognition-Enhancing Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 90. Asia Cognition-Enhancing Drugs Revenue by Region (2019-2024) & (US$ Million)
    Table 91. Asia Cognition-Enhancing Drugs Revenue by Region (2025-2030) & (US$ Million)
    Table 92. Asia Cognition-Enhancing Drugs Sales by Region (2019-2024) & (K MT)
    Table 93. Asia Cognition-Enhancing Drugs Sales by Region (2025-2030) & (K MT)
    Table 94. Middle East, Africa and Latin America Cognition-Enhancing Drugs Sales by Type (2019-2024) & (K MT)
    Table 95. Middle East, Africa and Latin America Cognition-Enhancing Drugs Sales by Type (2025-2030) & (K MT)
    Table 96. Middle East, Africa and Latin America Cognition-Enhancing Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 97. Middle East, Africa and Latin America Cognition-Enhancing Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Cognition-Enhancing Drugs Sales by Application (2019-2024) & (K MT)
    Table 99. Middle East, Africa and Latin America Cognition-Enhancing Drugs Sales by Application (2025-2030) & (K MT)
    Table 100. Middle East, Africa and Latin America Cognition-Enhancing Drugs Revenue by Application (2019-2024) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Cognition-Enhancing Drugs Revenue by Application (2025-2030) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Cognition-Enhancing Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 103. Middle East, Africa and Latin America Cognition-Enhancing Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Cognition-Enhancing Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Cognition-Enhancing Drugs Sales by Country (2019-2024) & (K MT)
    Table 106. Middle East, Africa and Latin America Cognition-Enhancing Drugs Sales by Country (2025-2030) & (K MT)
    Table 107. Accelerated Intelligence Company Information
    Table 108. Accelerated Intelligence Description and Major Businesses
    Table 109. Accelerated Intelligence Cognition-Enhancing Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 110. Accelerated Intelligence Cognition-Enhancing Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Accelerated Intelligence Recent Developments
    Table 112. Cognition Therapeutics Company Information
    Table 113. Cognition Therapeutics Description and Major Businesses
    Table 114. Cognition Therapeutics Cognition-Enhancing Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 115. Cognition Therapeutics Cognition-Enhancing Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Cognition Therapeutics Recent Developments
    Table 117. Cogstate Company Information
    Table 118. Cogstate Description and Major Businesses
    Table 119. Cogstate Cognition-Enhancing Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 120. Cogstate Cognition-Enhancing Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Cogstate Recent Developments
    Table 122. HVMN Company Information
    Table 123. HVMN Description and Major Businesses
    Table 124. HVMN Cognition-Enhancing Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 125. HVMN Cognition-Enhancing Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. HVMN Recent Developments
    Table 127. Biogen Idec Company Information
    Table 128. Biogen Idec Description and Major Businesses
    Table 129. Biogen Idec Cognition-Enhancing Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 130. Biogen Idec Cognition-Enhancing Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Biogen Idec Recent Developments
    Table 132. Key Raw Materials Lists
    Table 133. Raw Materials Key Suppliers Lists
    Table 134. Cognition-Enhancing Drugs Distributors List
    Table 135. Cognition-Enhancing Drugs Customers List
    Table 136. Cognition-Enhancing Drugs Market Trends
    Table 137. Cognition-Enhancing Drugs Market Drivers
    Table 138. Cognition-Enhancing Drugs Market Challenges
    Table 139. Cognition-Enhancing Drugs Market Restraints
    Table 140. Research Programs/Design for This Report
    Table 141. Key Data Information from Secondary Sources
    Table 142. Key Data Information from Primary Sources
List of Figures
    Figure 1. Cognition-Enhancing Drugs Product Picture
    Figure 2. Global Cognition-Enhancing Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Cognition-Enhancing Drugs Market Share by Type in 2023 & 2030
    Figure 4. Oral Product Picture
    Figure 5. Injection Product Picture
    Figure 6. Global Cognition-Enhancing Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Cognition-Enhancing Drugs Market Share by Application in 2023 & 2030
    Figure 8. Hospital Pharmacies
    Figure 9. Drug Stores
    Figure 10. Retail Pharmacies
    Figure 11. Cognition-Enhancing Drugs Report Years Considered
    Figure 12. Global Cognition-Enhancing Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Cognition-Enhancing Drugs Revenue 2019-2030 (US$ Million)
    Figure 14. Global Cognition-Enhancing Drugs Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 15. Global Cognition-Enhancing Drugs Revenue Market Share by Region (2019-2030)
    Figure 16. Global Cognition-Enhancing Drugs Sales 2019-2030 ((K MT)
    Figure 17. Global Cognition-Enhancing Drugs Sales Market Share by Region (2019-2030)
    Figure 18. US & Canada Cognition-Enhancing Drugs Sales YoY (2019-2030) & (K MT)
    Figure 19. US & Canada Cognition-Enhancing Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 20. Europe Cognition-Enhancing Drugs Sales YoY (2019-2030) & (K MT)
    Figure 21. Europe Cognition-Enhancing Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 22. China Cognition-Enhancing Drugs Sales YoY (2019-2030) & (K MT)
    Figure 23. China Cognition-Enhancing Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 24. Asia (excluding China) Cognition-Enhancing Drugs Sales YoY (2019-2030) & (K MT)
    Figure 25. Asia (excluding China) Cognition-Enhancing Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 26. Middle East, Africa and Latin America Cognition-Enhancing Drugs Sales YoY (2019-2030) & (K MT)
    Figure 27. Middle East, Africa and Latin America Cognition-Enhancing Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 28. The Cognition-Enhancing Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 29. The Top 5 and 10 Largest Manufacturers of Cognition-Enhancing Drugs in the World: Market Share by Cognition-Enhancing Drugs Revenue in 2023
    Figure 30. Global Cognition-Enhancing Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 31. Global Cognition-Enhancing Drugs Sales Market Share by Type (2019-2030)
    Figure 32. Global Cognition-Enhancing Drugs Revenue Market Share by Type (2019-2030)
    Figure 33. Global Cognition-Enhancing Drugs Sales Market Share by Application (2019-2030)
    Figure 34. Global Cognition-Enhancing Drugs Revenue Market Share by Application (2019-2030)
    Figure 35. US & Canada Cognition-Enhancing Drugs Sales Market Share by Type (2019-2030)
    Figure 36. US & Canada Cognition-Enhancing Drugs Revenue Market Share by Type (2019-2030)
    Figure 37. US & Canada Cognition-Enhancing Drugs Sales Market Share by Application (2019-2030)
    Figure 38. US & Canada Cognition-Enhancing Drugs Revenue Market Share by Application (2019-2030)
    Figure 39. US & Canada Cognition-Enhancing Drugs Revenue Share by Country (2019-2030)
    Figure 40. US & Canada Cognition-Enhancing Drugs Sales Share by Country (2019-2030)
    Figure 41. U.S. Cognition-Enhancing Drugs Revenue (2019-2030) & (US$ Million)
    Figure 42. Canada Cognition-Enhancing Drugs Revenue (2019-2030) & (US$ Million)
    Figure 43. Europe Cognition-Enhancing Drugs Sales Market Share by Type (2019-2030)
    Figure 44. Europe Cognition-Enhancing Drugs Revenue Market Share by Type (2019-2030)
    Figure 45. Europe Cognition-Enhancing Drugs Sales Market Share by Application (2019-2030)
    Figure 46. Europe Cognition-Enhancing Drugs Revenue Market Share by Application (2019-2030)
    Figure 47. Europe Cognition-Enhancing Drugs Revenue Share by Country (2019-2030)
    Figure 48. Europe Cognition-Enhancing Drugs Sales Share by Country (2019-2030)
    Figure 49. Germany Cognition-Enhancing Drugs Revenue (2019-2030) & (US$ Million)
    Figure 50. France Cognition-Enhancing Drugs Revenue (2019-2030) & (US$ Million)
    Figure 51. U.K. Cognition-Enhancing Drugs Revenue (2019-2030) & (US$ Million)
    Figure 52. Italy Cognition-Enhancing Drugs Revenue (2019-2030) & (US$ Million)
    Figure 53. Russia Cognition-Enhancing Drugs Revenue (2019-2030) & (US$ Million)
    Figure 54. China Cognition-Enhancing Drugs Sales Market Share by Type (2019-2030)
    Figure 55. China Cognition-Enhancing Drugs Revenue Market Share by Type (2019-2030)
    Figure 56. China Cognition-Enhancing Drugs Sales Market Share by Application (2019-2030)
    Figure 57. China Cognition-Enhancing Drugs Revenue Market Share by Application (2019-2030)
    Figure 58. Asia Cognition-Enhancing Drugs Sales Market Share by Type (2019-2030)
    Figure 59. Asia Cognition-Enhancing Drugs Revenue Market Share by Type (2019-2030)
    Figure 60. Asia Cognition-Enhancing Drugs Sales Market Share by Application (2019-2030)
    Figure 61. Asia Cognition-Enhancing Drugs Revenue Market Share by Application (2019-2030)
    Figure 62. Asia Cognition-Enhancing Drugs Revenue Share by Region (2019-2030)
    Figure 63. Asia Cognition-Enhancing Drugs Sales Share by Region (2019-2030)
    Figure 64. Japan Cognition-Enhancing Drugs Revenue (2019-2030) & (US$ Million)
    Figure 65. South Korea Cognition-Enhancing Drugs Revenue (2019-2030) & (US$ Million)
    Figure 66. China Taiwan Cognition-Enhancing Drugs Revenue (2019-2030) & (US$ Million)
    Figure 67. Southeast Asia Cognition-Enhancing Drugs Revenue (2019-2030) & (US$ Million)
    Figure 68. India Cognition-Enhancing Drugs Revenue (2019-2030) & (US$ Million)
    Figure 69. Middle East, Africa and Latin America Cognition-Enhancing Drugs Sales Market Share by Type (2019-2030)
    Figure 70. Middle East, Africa and Latin America Cognition-Enhancing Drugs Revenue Market Share by Type (2019-2030)
    Figure 71. Middle East, Africa and Latin America Cognition-Enhancing Drugs Sales Market Share by Application (2019-2030)
    Figure 72. Middle East, Africa and Latin America Cognition-Enhancing Drugs Revenue Market Share by Application (2019-2030)
    Figure 73. Middle East, Africa and Latin America Cognition-Enhancing Drugs Revenue Share by Country (2019-2030)
    Figure 74. Middle East, Africa and Latin America Cognition-Enhancing Drugs Sales Share by Country (2019-2030)
    Figure 75. Brazil Cognition-Enhancing Drugs Revenue (2019-2030) & (US$ Million)
    Figure 76. Mexico Cognition-Enhancing Drugs Revenue (2019-2030) & (US$ Million)
    Figure 77. Turkey Cognition-Enhancing Drugs Revenue (2019-2030) & (US$ Million)
    Figure 78. Israel Cognition-Enhancing Drugs Revenue (2019-2030) & (US$ Million)
    Figure 79. GCC Countries Cognition-Enhancing Drugs Revenue (2019-2030) & (US$ Million)
    Figure 80. Cognition-Enhancing Drugs Value Chain
    Figure 81. Cognition-Enhancing Drugs Production Process
    Figure 82. Channels of Distribution
    Figure 83. Distributors Profiles
    Figure 84. Bottom-up and Top-down Approaches for This Report
    Figure 85. Data Triangulation
    Figure 86. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Brigatinib Tablet Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-13E9982
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Durezol Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-22W864
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Rats Model Services Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-39V834
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Argininemia Drugs Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-11E9950
Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions